| 1 Basic research1. 1 Disease specific divergence of T cell receptor (TCR) oligoclonality in juvenile idiopathic arthritis (JIA) 1.2 Serum and synovial fluid concentrations of … L WEDDERBURN, S VIGNOLA, M ALIKASIFOGLU, S OZEN, F OZALTIN, ... Annals of the Rheumatic Diseases 59 (9), 713-719, 2000 | | 2000 |
| 102 T cell adhesion to endothelial cells (EC) and transendothelial migration: Modulation by pertussis toxin (PT) and cholera toxin (CT) A Kavanaugh, PE Lipsky, N Oppenheimer-Marks Journal of Allergy and Clinical Immunology 87 (1), 164, 1991 | | 1991 |
| 102-wk clinical and radiologic results from the ATTRACT trial: a 2 year, randomized, controlled, phase 3 trial of infliximab (Remicade) in pts with active RA despite MTX P Lipsky Arthritis Rheum 43, 2000 | 69 | 2000 |
| 1104 Machine learning to determine the endotype of SLE patients: a validation study EL Hubbard, P Bachali, KM Kingsmore, AC Grammer, PE Lipsky Lupus Science & Medicine 11 (Suppl 2), 2024 | | 2024 |
| 1113 The transcriptomic landscape of nephritic kidneys reveals mechanisms for end organ resistance to damage in lupus-prone mice AR Daamen, H Wang, P Bachali, N Shen, KM Kingsmore, RD Robl, ... Lupus Science & Medicine 9 (Suppl 3), 2022 | | 2022 |
| 1122 Validation of a novel lupus multivariable outcome score as an outcome measure for systemtic lupus erythematosus trials M Abrahamowicz, PE Lipsky Lupus Science & Medicine 8 (Suppl 2), 2021 | | 2021 |
| 1202 Unveiling metabolic vulnerabilities in lupus B cells: targeting BCMA and glucose dependency for therapeutic strategies JJ Wilson, J Wei, AR Daamen, CL Mayberry, AC Grammer, PE Lipsky, ... Lupus Science & Medicine 11 (Suppl 2), 2024 | | 2024 |
| 1208 Differential reliance on glucose oxidation by activated autoreactive B cells provides a novel target of therapeutic intervention JJ Wilson, J Wei, AR Daamen, JD Sears, E Bechtel, CL Mayberry, ... Lupus Science & Medicine 9 (Suppl 3), 2022 | | 2022 |
| 1303 Bacterial DNA induces regulatory B cells and attenuates lupus through a B cell-extrinsic, TLR9-dependent mechanism MG Appiah, DN Oakland, J Zhu, X Cabana-Puig, R Lu, R Alajoleen, ... Lupus Science & Medicine 9 (Suppl 3), 2022 | | 2022 |
| 1402 Augmented glucose dependency of autoreactive B cells provides a treatment target for lupus JJ Wilson, J Wei, AR Daamen, JD Sears, E Bechtel, CL Mayberry, ... Lupus Science & Medicine 8 (Suppl 2), 2021 | | 2021 |
| 1707 Anti-RNP antibodies are associated with the interferon gene signature but not complement activation in SLE E Hubbard, DS Pisetsky, P Lipsky Lupus Science & Medicine 8 (Suppl 2), 2021 | | 2021 |
| 1995 national survey of US rheumatologists: beliefs and practices regarding therapy, referrals, managed care, guidelines and algorithms JJ Cush, AF Kavanaugh, PE Lipsky ARTHRITIS AND RHEUMATISM 39 (9), 821-821, 1996 | 3 | 1996 |
| 2 Classification of juvenile idiopathic arthritis2. 1 Evaluation of classification criteria for juvenile idiopathic arthritis (JIA) 2.2 Classification of juvenile idiopathic … M LANGKAMMERER, F FANTINI, R MERINO, L BERNTSON, ... Annals of the Rheumatic Diseases 59 (9), 719-720, 2000 | 2 | 2000 |
| 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis X Zhang, J Xia, Y Jiang, DS Pisetsky, JS Smolen, R Mu, S Dai, ... Journal of Autoimmunity 142, 103148, 2024 | 1 | 2024 |
| 2101 Gene Expression Profiling of Key Immune/Inflammatory Pathways Reveals Molecular Endotypes of SLE with Clinical Implications EL Hubbard, P Bachali, KM Kingsmore, Y He, MD Catalina, AC Grammer, ... Lupus Science & Medicine 9 (Suppl 3), 2022 | | 2022 |
| 2103 Molecular characterization of lupus nephritis kidneys and blood KM Kingsmore, S Shrotri, P Bachali, N Shen, A Grammer, P Lipsky Lupus Science & Medicine 9 (Suppl 3), 2022 | | 2022 |
| 251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus J Jordan, K Sweet, M Cesaroni, K Ma, C Franks, L Seridi, J Schreiter, ... Lupus Science & Medicine 6 (Suppl 1), 2019 | 2 | 2019 |
| 3 Polyunsaturated fatty acids (PUFAs) and specialized pro-resolving mediators (SPMs) are decreased in plasma and serum from SLE patients compared to healthy controls J Davis-Porada, C Serhan, P Norris, P Lipsky, J Salmon Lupus Science & Medicine 6 (Suppl 1), 2019 | 2 | 2019 |
| 302 Transcriptomic analysis reveals a critical regulatory role for CD8 T cells in a mouse model of systemic lupus erythematosus AR Daamen, CH Chang, DC Roopenian, AC Grammer, PE Lipsky Lupus Science & Medicine 8 (Suppl 2), 2021 | | 2021 |
| 304 Metabolic dysregulation characterizes the tissue response to immune injury in systemic lupus erythematosus and inflammatory skin diseases KM Kingsmore, S Shrotri, BA Martinez, P Bachali, MD Catalina, ... Lupus Science & Medicine 8 (Suppl 2), 2021 | | 2021 |
